Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
A Colombian city swaps iconic horse buggies for electric carriages amid animal welfare concerns - 2Choosing Moving Styles for Your Restroom Redesign
- 3Qatar, Ireland accuse Israel of using chemical weapons on Palestinians, demand watchdog probe use
- 4Figure out How to Assess the Unwavering quality of SUVs for Seniors
- 5As cases of a rare, deadly infection rise, doctors worry fewer teens will get vaccinated
- China's Normal Ponders: A Visual Excursion
- 6 Novice Cameras for 2024: Ideal for New Picture takers
- Ancient meditation practices find new life in modern religious communities across America
- A 'rampaging lion' nebula roars to life in a stunning deep-space photo
- Vote In favor of Your Favored Web based Dating Application
- The World's Dazzling Regular Miracles
- Pick Your Favored method of transportation
- The Way to Business: Startup Illustrations Learned
- Why boosting production of Venezuela's 'very dense, very sloppy' oil could harm the environment
